1. Annual Meeting
9th December 2015

2. Mark Foster
Replace this photo with your own by going to Insert  Photo  Picture from File.

3. 2015/16 Annual Report

4. Total recorded usage
28,260,840 Grams

5. Estimated recorded cost
£847,825,000

6. Recorded yearly increase
Grams
% Increase
2012/13
3,185,000
11%
2013/14
3,675000
15%
2014/15
4,275,000
16%
2015/16
4,577000 6%

7. Recorded yearly usage

8. CMU sales comparison June 2015 – May 2016
Intravenous
88%
Sub-cutaneous
90%
Total Vs. CMU sales

9. Number of patients treated by year

10. Number of patients treated by region

11. Yearly Usage by Region

12. Average patient usage by region

13. Number of patients treated by Speciality

14. Yearly Usage by Speciality

15. Average patient usage by speciality

16. Average patient usage - Immunology
Condition
15/16 LY
PID
1,206,000
+8%
Secondary
285,000
+24%
Specific
53,477
+10%

17. Average patient usage – Neurology
Condition
15/16 LY
CIDP
910,000
+5%
MMN
454,000
+10% MG
173,000 -
Inflammatory myopathies
107,000 GB
137,000
+19%

18. Average patient usage – Haematology
Condition
15/16 LY
ITP - Acute
263,000
+17%
ITP – Persistent
67,000
+21%

19. Yearly usage by product type

20. Yearly intravenous product usage

21. Yearly subcutaneous product usage

22. Grey Usage 2011/12 –
Year
2011/12
2012/13
2013/14
20141/15
2015/16
Usage
143,870
158,951
184,498
204,944
208,922

23. Grey patients and outcomes2011/12 – 2015-16
Year
2011/12
2012/13
2013/14
2014/15
2015/16
Grey Requests
812
911
908
831
849
Outcomes
n/a
271
245
235
247
Percentage
30%
27%
28%
29%

24. Grey Usage

25. Grey Usage 2015-16 561 Grey unlisted requests since Jan 2015
4 Centres are responsible for half of these requests
10-20% of Grey unlisted are incorrectly registered
Tetanus – Most common incorrect registration

26. Outcomes recorded by speciality

27. Outcomes recorded by conditions

28. Outcomes recorded – Top region

29. Summary Increase in reported usage starting to level off
2015/16 saw highest capture Vs CMU sales
Further database improvements made to support the commissioning of Ig
NHS England utilising the database to develop policy
Database can help to identify cost saving opportunities
Focus on the collection of outcomes
Address incorrect Ig requests
Scotland and Northern Ireland now using the database

30. In need of IT Services? info@mdsas.com
THANK YOU
In need of IT Services?